Second-Quarter 2020 Business Performance Preannouncement

In light of the withdrawal of its annual objectives, bioMérieux, a world leader in the field of in vitro diagnostics, today announced preliminary quarterly information about its business activity ending June 30, 2020.

• Organic growth of 15.7% at constant exchange rates and scope of consolidation over the first half of 2020:
  
  • €1,476 million in sales
  • Up 15.8% as reported
• Sustained positive momentum of molecular biology product lines
• As expected, adverse impact of the global health crisis on microbiology, immunoassay and industrial applications product lines